|

Precision Medicine for Every Child With Cancer

RECRUITINGSponsored by Australian & New Zealand Children's Haematology/Oncology Group
Actively Recruiting
SponsorAustralian & New Zealand Children's Haematology/Oncology Group
Started2022-12-16
Est. completion2025-07
Eligibility
Age0 Years – 25 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05504772

Summary

To improve outcomes for childhood cancer patients through the implementation of precision medicine.

Eligibility

Age: 0 Years – 25 YearsHealthy volunteers accepted
Inclusion Criteria:

1. Age \< 18 years Note: Individual patients aged 19 - 25 years old with a pediatric cancer, e.g., neuroblastoma, may be enrolled after discussion with, and at the discretion of, the Study Chair or their delegate.
2. Life expectancy \>6 weeks at time of enrolment
3. Consent i. Signed and dated informed consent for study enrolment from participant aged ≥ 18 years or from parent/guardian of participant aged \<18 years. ii. Separate signed and dated informed consent for understanding the role of germline testing and choice for the return of germline results.

Conditions7

CancerChildhood Brain TumorChildhood CancerChildhood LeukemiaChildhood Solid TumorRefractory CancerRelapsed Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.